SCHEMBL3811074

SCHEMBL3811074

CNC(=O)c1ccc(Cl)cc1NC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 3/20 0.54
GLA P06280 1/20 0.54
GAA P10253 1/20 0.54
ALOX15 P16050 2/20 0.49
PYGL P06737 2/20 0.46
NUDT1 P36639 1/20 0.46
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KCNMA1 Q12791 3/20 0.45
MAPT P10636 1/20 0.44
NPC1 O15118 2/20 0.43
POLB P06746 2/20 0.42
THRB P10828 1/20 0.42
RECQL P46063 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PKM P14618 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9796166 0.83 KDM4E (0.56) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL1321725 0.83 KDM4E (0.63) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL3787454 0.82 ALDH1A1 (0.50) KDM4EALDH1A1GLAGAAALOX15
SCHEMBL23466539 0.82 KDM4E (0.50) KDM4EALDH1A1ALOX15PYGLKMT2A
SCHEMBL7169725 0.81 KDM4E (0.74) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL4154496 0.81 KDM4E (0.67) KDM4EALDH1A1GAAALOX15PYGL
SCHEMBL29833777 0.81 KDM4E (0.67) KDM4EALDH1A1GAAALOX15PYGL
SCHEMBL5875315 0.80 ABL1 (0.62) KDM4EALDH1A1GLAGAAKMT2A
SCHEMBL8318320 0.79 FLT1 (0.59) KDM4EALDH1A1ALOX15PYGLKMT2A
SCHEMBL14601264 0.79 HPGD (0.43) ALDH1A1GAAKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021110076-A1 OXAMIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE 深圳信立泰药业股份有限公司 2021-06-10 WO disclosed
US-7524855-B2 Selected benzofuran derivatives ARPIDA AG (CH) 2009-04-28 US disclosed
US-20080108610-A1 Selected Benzofuran Derivatives ARPIDA AG (CH) 2008-05-08 US disclosed
CN-101087779-A Selected benzofuran derivatives ARPIDA AG (CH) 2007-12-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108610-A1 Selected Benzofuran Derivatives ABCG2, BPTF, SBDS KDM4E 1756/4885ALDH1A1 972/4885GLA 1270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.